相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Uropathogenic Escherichia coli Subclone Sequence Type 131-H30 Is Responsible for Most Antibiotic Prescription Errors at an Urgent Care Clinic
Veronika Tchesnokova et al.
CLINICAL INFECTIOUS DISEASES (2019)
Application of Next-Generation Sequencing for Characterization of Surveillance and Clinical Trial Isolates: Analysis of the Distribution of β-lactamase Resistance Genes and Lineage Background in the United States
Rodrigo E. Mendes et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Comparative Activities of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Enterobacteriaceae Isolates Producing Extended-Spectrum β-Lactamases from US Hospitals
Mariana Castanheir et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Experiences in fosfomycin susceptibility testing and resistance mechanism determination in Escherichia coli from urinary tract infections in the UK
Jennifer L. Cottell et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2019)
Effect of outpatient antibiotics for urinary tract infections on antimicrobial resistance among commensal Enterobacteriaceae: a multinational prospective cohort study
A. J. Stewardson et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Fluoroquinolones for urinary tract infection and within-household spread of resistant Enterobacteriaceae: the smoking gun
Barbara W. Trautner
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae
Jesus Rodriguez-Bano et al.
CLINICAL MICROBIOLOGY REVIEWS (2018)
Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review
Annarita Mazzariol et al.
JOURNAL OF CHEMOTHERAPY (2017)
The Pandemic H30 Subclone of Sequence Type 131 (ST131) as the Leading Cause of Multidrug-Resistant Escherichia coli Infections in the United States (2011-2012)
James R. Johnson et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from US Medical Centers, 2013 to 2016
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Antimicrobial Resistance of Escherichia coli Urinary Isolates in the Veterans Affairs Health Care System
Haley J. Morrill et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Fluoroquinolone and Third-Generation-Cephalosporin Resistance among Hospitalized Patients with Urinary Tract Infections Due to Escherichia coli: Do Rates Vary by Hospital Characteristics and Geographic Region?
Monique R. Bidell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Gram-Negative Organisms Isolated from Patients with Urinary Tract Infections in US Medical Centers, 2012 to 2014
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
The Pandemic H30 Subclone of Escherichia coli Sequence Type 131 Is Associated With Persistent Infections and Adverse Outcomes Independent From Its Multidrug Resistance and Associations With Compromised Hosts
James R. Johnson et al.
CLINICAL INFECTIOUS DISEASES (2016)
The clinical impact of ST131 H30-Rx subclone in urinary tract infections due to multidrug-resistant Escherichia coli
Fusun Can et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2016)
Emerging Escherichia coli O25b/ST131 Clone Predicts Treatment Failure in Urinary Tract Infections
Fusun Can et al.
CLINICAL INFECTIOUS DISEASES (2015)
Contemporary Diversity of β-Lactamases among Enterobacteriaceae in the Nine US Census Regions and Ceftazidime-Avibactam Activity Tested against Isolates Producing the Most Prevalent β-Lactamase Groups
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Characterization of Escherichia coli Isolates from Hospital Inpatients or Outpatients with Urinary Tract Infection
Francisco Toval et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Global dissemination of a multidrug resistant Escherichia coli clone
Nicola K. Petty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Antimicrobial Susceptibility of Inpatient Urinary Tract Isolates of Gram-Negative Bacilli in the United States: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program: 2009-2011
Sam K. Bouchillon et al.
CLINICAL THERAPEUTICS (2013)
Trends in Klebsiella pneumoniae carbapenemase-positive K. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program
Robyn M. Kaiser et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Positively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformation
Drew J. Schwartz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The CTX-M-15-Producing Escherichia coli Clone O25b: H4-ST131 Has High Intestine Colonization and Urinary Tract Infection Abilities
Sophie Vimont et al.
PLOS ONE (2012)
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
Kalpana Gupta et al.
CLINICAL INFECTIOUS DISEASES (2011)
Extended-spectrum beta-lactamase-producing enterobacteriaceae: an emerging public-health concern
Johann D. D. Pitout et al.
LANCET INFECTIOUS DISEASES (2008)
First report of the emergence of CTX-M-Type extended-spectrum β-lactamases (ES-BLs) as the predominant ESBL isolated in a US health care Systemdel
James S. Lewis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Antibiotic coresistance in extended-spectrum-β-lactamase-producing Enterobacteriaceae and in vitro activity of tigecycline
Maria-Isabel Morosini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
High levels of antimicrobial coresistance among extended-spectrum-β-lactamase-producing Enterobacteriaceae
MJ Schwaber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
A UK Multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection
DJ Farrell et al.
JOURNAL OF INFECTION (2003)
Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States
JA Karlowsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for infection and impact of resistance on outcomes
E Lautenbach et al.
CLINICAL INFECTIOUS DISEASES (2001)
分享论文
